Methods and compositions for CAR T cell therapy

A composition and cell technology, applied in the field of CAR T cell therapy and composition

Pending Publication Date: 2019-01-11
PURDUE RES FOUND INC +1
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

First, 'off-target' toxicity may occur due to normal cells expressing antigens targeted by CART cells (e.g., tumor-associated antigens)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and compositions for CAR T cell therapy
  • Methods and compositions for CAR T cell therapy
  • Methods and compositions for CAR T cell therapy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0309] Preparation of lentiviral vector encoding CAR gene

[0310] An overlap PCR approach was used to generate CAR constructs containing scFv against fluorescein. A scFv against fluorescein was synthesized, namely 4M5.3 (Kd = 270 fM, 762 bp) derived from an anti-fluorescein (4-4-20) antibody. Encoding human CD8α signal peptide (SP, 63 bp), hinge and transmembrane region (249 bp), cytoplasmic domain of 4-1BB (CD137, 141 bp) as shown in Figure 14A by overlap PCR pairs) and the sequence of the CD3ζ chain (336 bp) were fused to anti-fluorescein scFv. The resulting CAR construct (1551 bp) was inserted into the EcoRI / NotI cut lentiviral expression vector pCDH-EF1-MCS-(PGK-GFP) ( FIG. 14B , System Biosciences). The sequence of the CAR construct in the lentiviral vector was confirmed by DNA sequencing.

[0311] An exemplary CAR nucleic acid coding sequence may comprise:

[0312]

[0313] .

[0314] In the exemplary nucleic acid sequences shown above, the first ATG is the ...

Embodiment 2

[0322] Preparation of Lentivirus Containing CAR Gene for Transduction of Human T Cells

[0323] To generate lentivirus containing an anti-fluorescein single-chain fragment variable (scFv) CAR, the 293TN packaging cell line was co-transfected with a mixture of lentiviral vector encoding anti-fluorescein scFvCAR and a second-generation packaging plasmid (Cellecta). After 24 and 48 hours of transfection, supernatants containing lentiviruses with CAR genes were harvested and viral particles were concentrated for future human T cell transductions by standard polyethylene glycol virus enrichment methods (Clontech) .

Embodiment 3

[0325] Isolation of Human T Cells from Human PBMCs

[0326] T cells were isolated from human peripheral blood mononuclear cells (PBMC) by Ficoll density gradient centrifugation (GE Healthcare Lifesciences). After washing away the residual Ficoll solution, T cells were isolated using the EasySep™ Human T Cell Isolation Kit (STEM CELL technologies). Purified T cells were cultured in TexMACS™ medium (Miltenyi Biotech Inc) containing 1% penicillin and streptomycin sulfate in the presence of human IL-2 (100 IU / mL, Miltenyi Biotech Inc). In multi-well plates at 1x10 6 T cells were cultured at a density of 1 cell / mL. T cells were split and re-fed every 2-3 days.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present disclosure relates to methods of treating a patient with a cancer by administering to the patient a composition comprising CAR T cells and a small molecule linked to a targeting moiety bya linker. The disclosure also relates to compositions for use in such methods.

Description

[0001] Cross References to Related Applications [0002] This application claims under Title 35, United States Code, Section 119(e) of U.S. Provisional Application Serial No. 62 / 320,183, filed April 8, 2016, and U.S. Provisional Application Serial No. 62 / 323,971, filed April 18, 2016 priority, both of which are hereby incorporated by reference in their entirety. technical field [0003] The present invention relates to a method of treating a patient with cancer by administering to the patient a composition comprising CAR T cells and administering to the patient a small molecule linked to a targeting moiety via a linker. The invention also relates to compositions for use in such methods. Background of the invention [0004] Immunotherapy based on the adoptive transfer of lymphocytes (eg, T cells) into patients is a valuable therapy in the treatment of cancer and other diseases. Many important advances have been made in the development of immunotherapies based on adoptive tr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/17A61K39/00C07K16/00
CPCA61K35/12A61K39/39558A61K9/0019A61K48/005A61K35/17C07K16/44C12N15/86A61K2039/505C07K2317/622C07K2317/73C07K2319/03C07K2319/33C12N2740/16043A61K47/551A61K47/555A61P35/00A61K2300/00A61K39/0011A61K2039/5156C07K14/7051C07K14/70517C07K2317/92C07K2319/02C12N2740/15043
Inventor P.S.罗H.楚Y.G.李
Owner PURDUE RES FOUND INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap